Connect with us
Information

WORLD EDITION
Australia
North America
World

Investing News NetworkYour trusted source for investing success

WORLD EDITION
North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

denali therapeutics

POPULAR ARTICLES

Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL747 for Alzheimer’s Disease

Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL201 for Parkinson’s Disease

Denali Therapeutics Announces Positive Clinical Results With Its Lead RIPK1 Inhibitor Molecule

LATEST ARTICLES

NASDAQ:DNLI

Denali Therapeutics Partners with Sanofi

Denali Therapeutics Announces Broad Collaboration with Sanofi to Develop RIPK1 Inhibitors

CENTOGENE and Denali Therapeutics Announce Strategic Collaboration to Recruit LRRK2 Patients for Clinical Trials

Latest News

Galan Declines AU$240M Bid for Argentina Projects

Close of Takeover Offer

Altech Batteries Ltd CERENERGY at Hannover International Industrial Fair

Alvopetro Announces March 2025 Sales Volumes

FREEGOLD ANNOUNCES CLOSING OF $42 MILLION BROKERED PRIVATE PLACEMENT FINANCING